Published: 26/08/19

Hormone Replacement herapy (HRT) Supply Issues

This Circular advises community pharmacy contractors and NHS Boards with the latest update on the availability of all Hormone Replacement Therapy (HRT) products marketed in the UK.

The table 1 attached at Annex A provides the latest update on the availability of all HRT products marketed in the UK and the known resupply date for products that are currently experiencing supply issues.

The table also provides an update of all HRT preparations that remain available. Clinicians may be required to switch patients to alternative HRT products that contain the same active ingredients for a temporary period.

Prescribing information regarding HRT equivalence to support local decision making is available through various sources such as the British National Formulary, Summary of Product Characteristics (SPC), The Monthly Index of Medical Specialities (MIMS), and other sources including local Medicines Information Centres.